The program of the 2017 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference covers all areas of inquiry in cancer immunology and immunotherapy, including: neoantigens and vaccines, novel mechanisms of immunosuppression and immune evasion, biomarkers, microbiota, oncolytic viruses,
new agents and their mode of action, combination therapies, adoptive cell therapies, new checkpoints, non-checkpoint immunotherapies, and the tumor microenvironment. The meeting provides an unparalleled opportunity for teaching,
learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and
patient advocates.